John Archie

John Archie, MBA, is a seasoned professional in the pharmaceutical industry with extensive experience in account management and business development. Currently serving as the National Account Director for Oncology GPO at Eagle Pharmaceuticals, Inc. since December 2022, John has held key positions including National Director of Corporate Accounts at Myovant Sciences and GPO Manufacturer Sales & Solutions at Cardinal Health. Prior roles include Director of Business Development at McKesson, Oncology Specialty Consultant at ProStrakan, and various sales positions at Solvay Pharmaceuticals, BioMarin Pharmaceutical Inc., Merck, and Ortho-McNeil Pharmaceutical. John Archie earned an MBA in Business Management from Indiana Wesleyan University (2004 - 2006) and a BA from Wabash College (1992 - 1996).